Norwich-based Evaro secures €1.4 million to create digital clinics for consumer brands

Evaro raises $1.5M Seed funding to help consumer brands offer pharma prescriptions

Evaro Raises $1.5M in Seed Funding

Evaro, a UK-based digital health startup, has secured €1.4 million in seed funding led by Cornerstone VC and Exceptional Ventures. The funding will be used to expand Evaro's offering to the B2B market, allowing consumer brands to offer managed medication prescription services to their customers. Evaro's unique B2B model provides a plug-and-play solution for brands to venture into the digital health space without the complexities of technology, regulation, and fulfillment. The company aims to grow its medication catalogue from 200 to 2,000 treatments, covering 70% of minor health issues typically addressed by NHS doctors, and acquire its Care Quality Commission (CQC) licence for more comprehensive patient care.

Evaro Raises €1.4 Million to Expand Digital Clinics for Consumer Brands

Evaro is a UK-based digital health startup providing AI-powered clinical and drug prescription services for minor conditions. Founded in 2018 by Dr. Thuria Wenbar and Dr. Oskar Wendowski, Evaro aims to provide scalable, safe, and affordable healthcare through a self-service model focused on routine health needs. The company offers a B2B "pharmaceutical infrastructure as a service" model, allowing consumer brands to offer managed medication prescription services to their customers. Evaro uses an AI and machine learning model trained on 13.5 million patient records to provide access to AI-driven asynchronous consultations and private prescription medication. It also employs a stringent regulatory-compliant patient safety process, ensuring safe and efficient online healthcare.

A UK-based digital health startup providing AI-powered clinical and drug prescription services for minor conditions.

2 years ago

Evaro Raises €1.4 Million to Expand Digital Clinics for Consumer Brands

ProblemHealthcare

Solution

Covered on